ENOXABARA® Enoxaparin 40 mg | Libya (BAYADERCARE)
Advanced solution designed to reduce the risk of thrombosis and improve patient safety.
Enoxaparin 40 mg Injection | BAYADERCARE Libya
Preventive anticoagulation is a key component in modern clinical care, particularly in reducing the risk of thromboembolic complications in surgical and immobilized patients. Low molecular weight heparins (LMWH) are widely used across Libyan healthcare settings due to their predictable pharmacokinetics, safety profile, and ease of administration.
|
ENOXABARA® 40 mg (Enoxaparin Sodium Injection) is a low molecular weight heparin (LMWH) used for the prevention of thromboembolic disorders. It works by inhibiting factor Xa activity, reducing clot formation and maintaining stable blood flow.
|
| Applications / Uses: |
| Prevention of Deep Vein Thrombosis (DVT) |
| Post-surgical thromboprophylaxis |
| Prevention of Venous Thromboembolism (VTE) |
| Anticoagulant support in immobilized patients |
| Hospital-based preventive protocols |
FAQ
Is ENOXABARA 40 mg available in Libya?
Yes, it is available through BAYADERCARE across Libya.
What is it used for?
| Prevention of thromboembolic conditions such as DVT. |
Where is it used?
| Hospitals, surgical units, and clinics. |
Enoxabara Enoxaparin 60 mg Injection
Enoxabara Enoxaparin 60 mg Anti-Xa injection for anticoagulant support and thrombosis prevention in Libya.
